ADVATE (octocog): Reviews and patient testimonials
Medication indications
ADVATE 250 IU, 500 IU, 1000 IU, 1500 IU powder and solvent for solution for injection 2 ml solvent
Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). ADVATE is indicated in all age groups.
ADVATE 250 IU, 500 IU,1000 IU, 1500 IU, 2000 IU and 3000 IU powder and solvent for solution for injection 5 ml solvent
Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). ADVATE is indicated in all age groups.
Route of administration: Injectable
Molecule: octocog
Patients' opinions on ADVATE
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.